Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy

KCI Citation Count: 1

Saved in:

Bibliographic Details
Published in	The Korean journal of internal medicine Vol. 31; no. 3; pp. 601 - 604
Main Authors	Han, Sun Ae, Yoon, Young Min, Lee, Wan Soo, Kim, Yun Sung, Shin, Byung Chul, Chung, Jong Hoon, Kim, Hyun Lee
Format	Journal Article
Language	English
Published	Korea (South) The Korean Association of Internal Medicine 01.05.2016 대한내과학회
Subjects	Adalimumab - therapeutic use Adult Amyloidosis - diagnosis Amyloidosis - drug therapy Amyloidosis - immunology Anti-Inflammatory Agents - therapeutic use Arthritis, Juvenile - complications Arthritis, Juvenile - diagnosis Arthritis, Juvenile - drug therapy Arthritis, Juvenile - immunology Biopsy Cyclophosphamide - therapeutic use Drug Therapy, Combination Female Glucocorticoids - therapeutic use Humans Immunosuppressive Agents - therapeutic use Letter to the Editor Remission Induction Treatment Failure Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor Necrosis Factor-alpha - immunology 내과학 Cyclophosphamide Amyloidosis Juvenile idiopathic arthritis
Online Access	Get full text

Loading…